Circadian gene variants in cancer

Area of Science:

• Chronobiology
• Molecular Biology
• Oncology

Background:

• Human physiology exhibits daily oscillations governed by an endogenous circadian clock.
• Modern lifestyles frequently disrupt circadian homeostasis, elevating disease risk, notably cancer.
• The molecular clock regulates cell proliferation, metabolism, DNA repair, and apoptosis.

Purpose of the Study:

• To explore the association between circadian gene defects and cancer risk.
• To investigate the impact of circadian rhythm disruption on molecular clock function.
• To highlight circadian disruption as an independent cancer risk factor.

Main Methods:

• Review of recent studies on circadian gene mutations (SNP, deletion, deregulation, epigenetic silencing) in humans and animal models.
• Analysis of research linking lifestyle-induced circadian disruption to cancer development.
• Examination of the mechanisms underlying clock-controlled tumor suppression.

Main Results:

• Defects in circadian genes are strongly linked to increased cancer susceptibility.
• Circadian rhythm disruption can impair peripheral tissue molecular clocks independently of gene mutations.
• Circadian disruption is recognized as a significant, independent risk factor for cancer.

Conclusions:

• Understanding circadian clock-controlled tumor suppression is crucial for advancing cancer prevention and treatment.
• Targeting circadian pathways may offer novel therapeutic strategies.
• Maintaining circadian homeostasis is essential for reducing cancer risk.